Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

Electrophysiological and neurocognitive correlates and predictors of antidepressant response to single and dual pharmacotherapies

EF 2008-09

Résumé
Although major depressive disorder (MDD) is an enormous health problem, the effectiveness of currently available therapies is moderate. Animal work suggests that administering two different antidepressant drugs as initial treatment is more effective than administration of a single antidepressant drug. Previous research also indicates that individuals suffering from MDD may have distinguishable brain activity, as measured by electroencephalogram (EEG) recordings, from healthy individuals. Furthermore, there is accumulating evidence that specific patterns of brain activity in depressed individuals may be used to predict whether or not they will be responsive to a particular antidepressant treatment. Individuals with MDD also tend to exhibit differences in performance on simple computerized tasks that tap into aspects of cognitive processing and sensory perception. For instance, depressed individuals have been shown to exhibit alterations in attention as well as in the perception of emotional stimuli; they tend to be hyper-responsive to cues typically associated with negative emotions (e.g. a sad face). The primary aim of this study is to verify whether brain activity and performance on simple cognitive tasks can be used for distinguishing individuals with MDD from healthy controls and whether single and combined antidepressant treatment normalizes these parameters. Secondly, we will assess if brain activity and task performance shortly after treatment initiation can be used to predict response outcome to treatment with single or dual antidepressants. This study hopes to develop tools, such as brain activity recordings and performance on simple tasks tapping into basic cognitive processes, which will aid clinicians in determining who will be most responsive to a particular kind of antidepressant drug or a combination of drugs. This would help alleviate symptoms faster and lessen the burden of MDD on the health care system and on society as a whole.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184542
Name
Jaworska Natalia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Electrophysiological and neurocognitive correlates and predictors of antidepressant response to single and dual pharmacotherapies
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antidepressant Pharmacotherapy; Attention; Behavioral Tests; Clinical Trial; Cognitive Tests; Depression; Emotional Processing; Event Related Potentials (Erp); Longitudinal Study; Sensory Processing
Abstract
Although major depressive disorder (MDD) is an enormous health problem, the effectiveness of currently available therapies is moderate. Animal work suggests that administering two different antidepressant drugs as initial treatment is more effective than administration of a single antidepressant drug. Previous research also indicates that individuals suffering from MDD may have distinguishable brain activity, as measured by electroencephalogram (EEG) recordings, from healthy individuals. Furthermore, there is accumulating evidence that specific patterns of brain activity in depressed individuals may be used to predict whether or not they will be responsive to a particular antidepressant treatment. Individuals with MDD also tend to exhibit differences in performance on simple computerized tasks that tap into aspects of cognitive processing and sensory perception. For instance, depressed individuals have been shown to exhibit alterations in attention as well as in the perception of emotional stimuli; they tend to be hyper-responsive to cues typically associated with negative emotions (e.g. a sad face). The primary aim of this study is to verify whether brain activity and performance on simple cognitive tasks can be used for distinguishing individuals with MDD from healthy controls and whether single and combined antidepressant treatment normalizes these parameters. Secondly, we will assess if brain activity and task performance shortly after treatment initiation can be used to predict response outcome to treatment with single or dual antidepressants. This study hopes to develop tools, such as brain activity recordings and performance on simple tasks tapping into basic cognitive processes, which will aid clinicians in determining who will be most responsive to a particular kind of antidepressant drug or a combination of drugs. This would help alleviate symptoms faster and lessen the burden of MDD on the health care system and on society as a whole.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jaworska, Natalia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~